Constellation Brands (NYSE: STZ) reported fiscal second-quarter results that topped analyst expectations, yet the stock initially slipped before recovering. The company posted earnings per share of $3.74 on revenue of $2.63 billion, both comfortably ahead of Street estimates. However, management left its full-year guidance unchanged, which triggered an early selloff before shares turned positive in morning trading.
Jim Cramer, host of CNBC's Mad Money, offered a "perfectly plausible explanation" for the initial dip. According to Cramer, investors interpreted the unchanged guidance as a signal that "this may be the last good number." But during the earnings call, management indicated that if momentum continued in September, the company would likely come in at the top end of its guided range. That reassurance helped the stock recover its after-market losses.
Despite the upbeat tone, Cramer remains cautious on Constellation Brands shares. He pointed to the rising popularity of GLP-1 weight-loss treatments and a younger generation that prioritizes health, creating a challenging demand backdrop for alcoholic beverages. "Beer margins are just not that great; we don't have the growth we used to have," he said on CNBC's Squawk on the Street, making STZ less attractive as a long-term holding in late 2026.
From a technical perspective, the beer, wines, and spirits specialist trades firmly below its key moving averages, indicating that bears remain in control across multiple timeframes. "There are a lot of issues" with Constellation Brands, Cramer concluded.
The company's fiscal 2027 guidance projects EPS between $11.20 and $11.90, with sales expected to remain flat at the midpoint of its range. As of writing, STZ shares are still down more than 15% year-to-date.
SpikedAde Acquisition Raises Questions
Constellation Brands is spending approximately $75 million upfront on the acquisition of SpikedAde, with a total deal potential of $353 million. This move risks repeating past beverage industry missteps: committing capital to a category near its cyclical peak. While ready-to-drink options dominate retail shelf space, consumer preferences in low-alcohol and flavored beverages shift quickly, leaving major distributors vulnerable to sudden demand declines once novelty fades.
The deal could stretch balance sheet flexibility to chase inorganic volume growth as beer margins stabilize. If SpikedAde's momentum falters under broader distribution, the transaction might stall cash flow allocation toward higher-margin core brands, yielding muted returns on a high-cost fad.
Wall Street currently rates STZ stock at overweight, with a bullish mean price target of about $160. Investors will be watching whether the company can sustain its momentum and whether the SpikedAde acquisition pays off.
This article is for informational purposes only and does not constitute financial advice.
